Brought to you by 
Merz acquires third aesthetics company within a year, pays $600mm for Ulthera
25 Sep 2020
Executive Summary
In its largest acquisition to date, and the third within a year in the aesthetics field, Merz North America Inc. (part of German drug company Merz GMBH & Co. KGAA’s Merz Pharma Group) will pay $600mm in up-front and earn-out payments for privately held Ulthera Inc.
Deal Industry
- Medical Devices
-
Medical Devices
-
Diagnostic Imaging Equipment & Supplies
- Ultrasound
-
Diagnostic Imaging Equipment & Supplies
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Merz acquires third aesthetics company within a year, pays $600mm for Ulthera
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice